OTC Healthcare in Uruguay
Euromonitor International's OTC Healthcare in Uruguay market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 102 | Publication date: May 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Declining unit prices curb value growth
In 2008, prices in all sectors continued to fall in current terms for the third consecutive year. The good performance in volume sales of most sectors was not sufficient to compensate for the drop in prices and the OTC healthcare market posted negative growth in constant terms for the fourth time during the review period. At private medical institutions, patients can obtain medicines by paying a ticket for each prescribed remedy. In an effort to capture new affiliates, these institutions have been reducing the cost of these tickets, which, according to a study from the Ministerio de Salud Pública, fell by 50% in constant value since 2004. Prices of OTC healthcare products, with few exceptions, also fell in order to remain a viable option for consumers who were willing to pay a bit more for the convenience of getting the remedies at a nearby pharmacy.
New health system firmly in place
The new Sistema Nacional Integrado de Salud (SNIS), after a shaky start as Fondo Nacional de Salud (FONASA) in August 2007, is now firmly in place since January 2008 as Bill No 18211, pending only minor operational adjustments. One of the operational aspects to be adjusted is the control of the number of doses per package delivered through SNIS private institution pharmacies, as it was found that in several instances it was not the same as for similar remedies sold OTC. If firm controls are established by the Ministerio de Salud Pública, it could result in an increase in the price of medicine tickets to be paid by users at private institutions, which in turn could benefit OTC sales.
Same players continue to dominate OTC sales
With more than 50 domestic and international pharmaceutical companies present in the OTC healthcare market, market share variations are typically rather small. However, two companies, top-ranking international company Bayer SA and second-ranking domestic company Spefar SA, had relatively distinguished performances relative to the rest of the market. Bayer SA is one of the longest established and trusted pharmaceutical companies in Uruguay, through an important presence in several sectors (leading in medicated skin care and vitamins and dietary supplements.). Spefar SA remained a leader mainly due to the success of its ibuprofen-based analgesics like Perifar, which again ranked as the best-selling medicine of the OTC market.
Government succeeding in fight against illegal trade
The Ministerio de Salud Pública’s multi-year campaign aimed at limiting purchases of medicines at street markets and ensuring that consumers obtain them only with a prescription through legally established channels seems to be succeeding, as value sales through pharmacies increased for the fourth consecutive year. The combined efforts of different government agencies led by the Ministerio de Salud Pública resulted in record seizures of illegal medicines during 2008.
Prices expected to increase
Long-term agreements with workers’ unions, which include a reintroduction of salary pegs to inflation, are already increasing production costs and the slow appreciation of the US dollar is also pushing up prices in local currency. This could most certainly put an end to the three-year long constant value price decline and with the expected moderate overall increase in consumption, begin boosting value sales during the forecast period.
Table of contents
OTC HEALTHCARE IN URUGUAY : MARKET INSIGHT
EXECUTIVE SUMMARY
Declining unit prices curb value growth
New health system firmly in place
Same players continue to dominate OTC sales
Government succeeding in fight against illegal trade
Prices expected to increase
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Generics
Switches
Summary 1 Summary - OTC Healthcare voluntary product repositionings 2006-2008
DEFINITIONS
Summary 2 Summary - Research Sources
LOCAL COMPANY PROFILES - URUGUAY
ANTIA MOLL & CIA SA - OTC HEALTHCARE - URUGUAY
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Summary - Antia Moll & Cia SA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Summary - Antia Moll & Cia SA: Competitive Position 2008
FARMACO URUGUAYO SA - OTC HEALTHCARE - URUGUAY
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Summary - Farmaco Uruguayo SA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 6 Summary - Farmaco Uruguayo SA: Competitive Position 2008
SERVIMEDIC SA - OTC HEALTHCARE - URUGUAY
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Summary - Servimedic SA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 8 Summary - Servimedic SA: Competitive Position 2008
ANALGESICS IN URUGUAY
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 11 Sales of Analgesics by Subsector: Value 2003-2008
Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 13 Herbal vs Standard Topical Analgesics 2003-2008
Table 14 Analgesics Company Shares by Value 2004-2008
Table 15 Analgesics Brand Shares by Value 2005-2008
Table 16 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 17 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN URUGUAY
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 20 Sales of Decongestants by Type: Value 2003-2008
Table 21 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 22 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 24 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 25 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 27 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN URUGUAY
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 29 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 30 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 31 Herbal vs Standard Digestive Remedies 2003-2008
Table 32 Digestive Remedies Company Shares by Value 2004-2008
Table 33 Digestive Remedies Brand Shares by Value 2005-2008
Table 34 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 35 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN URUGUAY
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 36 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 37 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 38 Herbal vs Standard Medicated Skin Care 2003-2008
Table 39 Medicated Skin Care Company Shares by Value 2004-2008
Table 40 Medicated Skin Care Brand Shares by Value 2005-2008
Table 41 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 42 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 43 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN URUGUAY
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 44 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 45 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 46 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 47 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 48 Vitamins Brand Shares by Value 2005-2008
Table 49 Dietary Supplements Brand Shares by Value 2005-2008
Table 50 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 51 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN URUGUAY
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 52 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 53 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 54 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 55 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 56 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 57 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 58 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
EYE CARE IN URUGUAY
HEADLINES
SECTOR DATA
Table 59 Sales of Eye Care by Subsector: Value 2003-2008
Table 60 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 61 Eye Care Company Shares by Value 2004-2008
Table 62 Eye Care Brand Shares by Value 2005-2008
Table 63 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 64 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
EAR CARE IN URUGUAY
HEADLINES
SECTOR DATA
Table 65 Sales of Ear Care: Value 2003-2008
Table 66 Sales of Ear Care: % Value Growth 2003-2008
Table 67 Ear Care Company Shares by Value 2004-2008
Table 68 Ear Care Brand Shares by Value 2005-2008
Table 69 Forecast Sales of Ear Care: Value 2008-2013
Table 70 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE IN URUGUAY
HEADLINES
SECTOR DATA
Table 71 Sales of Adult Mouth Care: Value 2003-2008
Table 72 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 73 Adult Mouth Care Company Shares by Value 2004-2008
Table 74 Adult Mouth Care Brand Shares by Value 2005-2008
Table 75 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 76 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN URUGUAY
HEADLINES
SECTOR DATA
Table 77 Sales of Calming and Sleeping Products: Value 2003-2008
Table 78 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 79 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 80 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 81 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 82 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
WOUND TREATMENTS IN URUGUAY
HEADLINES
SECTOR DATA
Table 83 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 84 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 85 Wound Treatments Company Shares by Value 2004-2008
Table 86 Wound Treatments Brand Shares by Value 2005-2008
Table 87 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 88 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
OTC OBESITY IN URUGUAY
HEADLINES
EMERGENCY CONTRACEPTION IN URUGUAY
HEADLINES
SECTOR DATA
Table 89 Sales of Emergency Contraception: Value 2003-2008
Table 90 Sales of Emergency Contraception: % Value Growth 2003-2008
Table 91 Emergency Contraception Company Shares by Value 2004-2008
Table 92 Emergency Contraception Brand Shares by Value 2005-2008
Table 93 Forecast Sales of Emergency Contraception: Value 2008-2013
Table 94 Forecast Sales of Emergency Contraception: % Value Growth 2008-2013
OTC TRIPTANS IN URUGUAY
HEADLINES